Hepatitis B virus (HBV) is a major risk factor for the development of hepat
ocellular carcinoma (HCC), HBV encodes the potentially oncogenic HBx protei
n, which mainly functions as a transcriptional co-activator involving in mu
ltiple gene deregulations. However, mechanisms underlying HBx-mediated onco
genicity remain unclear, To determine the role(s) of HBx in the early genes
is of HCC, we utilized the NCI Oncochip microarray that contains 2208 human
cDNA clones to examine the gene expression profiles in either freshly isol
ated normal primary adult human hepatocytes (Hhep) or an HCC cell line (SK-
Hep-l) ecotopically expressing HBx via an adenoviral system. The gene expre
ssion profiles also were determined in liver samples from HBV-infected chro
nic active hepatitis patients when compared with normal liver samples. The
microarray results were validated through Northern blot analysis of the exp
ression of selected genes. Using reciprocally labeling hybridizations, scat
terplot analysis of gene expression ratios in human primary hepatocytes exp
ressing HBx demonstrates that microarrays are highly reproducible. The comp
arison of gene expression profiles between HBx-expressing primary hepatocyt
es and HBV-infected liver samples shows a consistent alteration of many cel
lular genes including a subset of oncogenes (such as c-myc and c-myb) and t
umor suppressor genes (such as APC, p53, WAF1 and WT1), Furthermore, cluste
ring algorithm analysis showed distinctive gene expression profiles in Hhep
and SK-Hep-l cells. Our findings are consistent with the hypothesis that t
he deregulation of cellular genes by oncogenic HBx may be an early event th
at favors hepatocyte proliferation during liver carcinogenesis.